XERO LIMITED (XRO)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

XRO - XERO LIMITED

FNArena Sector : Accountancy
Year End: March
GICS Industry Group : Software & Services
Debt/EBITDA: 2.32
Index: ASX50 | ASX100 | ASX200 | ASX300 | ALL-ORDS | ALL-TECH

Xero Ltd is a New Zealand software company providing cloud-based accounting software platforms to small and medium sized businesses. Xero has over two million subscribers. Founded in 2006 the company listed in 2012 and has since expanded into Australia, the UK and the US.

LAST PRICE CHANGE +/- CHANGE % VOLUME

$130.58

20 Jun
2024

-0.300

OPEN

$131.00

-0.23%

HIGH

$131.35

438,651

LOW

$129.85

TARGET
$141.433 8.3% upside
Franking for last dividend paid out: 0%
OTHER COMPANIES IN THE SAME SECTOR
RKN .
FNARENA'S MARKET CONSENSUS FORECASTS
XRO: 1
Title FY25
Forecast
FY26
Forecast
EPS (cps) 145.3 xxx
DPS (cps) 0.0 xxx
EPS Growth N/A xxx
DPS Growth N/A xxx
PE Ratio 91.3 xxx
Dividend Yield 0.0% xxx
Div Pay Ratio(%) N/A xxx
This company reports in NZD.
All estimates have been converted into AUD by FNArena at present FX values.

Dividend yield today if purchased 3 years ago: N/A

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

N/A

Estimated Dividend Growth
(Average Of Past Three Years)

 %

Amount Invested

Tell Me The Dividend After This Many Years

Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages
HISTORICAL DATA ARE ALL IN AUD
Copyright © 2024 FactSet UK Limited. All rights reserved
Title 201920202021202220232024
EPS Basic xxxxxxxxxxxxxxx106.9
DPS All xxxxxxxxxxxxxxx0.0
Sales/Revenue xxxxxxxxxxxxxxx1,588.6 M
Book Value Per Share xxxxxxxxxxxxxxx838.6
Net Operating Cash Flow xxxxxxxxxxxxxxx548.5 M
Net Profit Margin xxxxxxxxxxxxxxx10.19 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 201920202021202220232024
Return on Capital Employed xxxxxxxxxxxxxxx14.32 %
Return on Invested Capital xxxxxxxxxxxxxxx7.33 %
Return on Assets xxxxxxxxxxxxxxx6.43 %
Return on Equity xxxxxxxxxxxxxxx14.32 %
Return on Total Capital xxxxxxxxxxxxxxx10.98 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx542.4 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 201920202021202220232024
Short-Term Debt xxxxxxxxxxxxxxx18 M
Long Term Debt xxxxxxxxxxxxxxx1,105 M
Total Debt xxxxxxxxxxxxxxx1,122 M
Goodwill - Gross xxxxxxxxxxxxxxx308 M
Cash & Equivalents - Generic xxxxxxxxxxxxxxx1,403 M
Price To Book Value xxxxxxxxxxxxxxx15.90

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 201920202021202220232024
Capex xxxxxxxxxxxxxxx230.4 M
Capex % of Sales xxxxxxxxxxxxxxx14.50 %
Cost of Goods Sold xxxxxxxxxxxxxxx417 M
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx927 M
Research & Development xxxxxxxxxxxxxxx295 M
Investments - Total xxxxxxxxxxxxxxx56 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.5

No. Of Recommendations

6
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Macquarie

xx/xx/xxxx

1

xxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Citi

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

UBS

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Morgans

24/05/2024

3

Hold

$140.00

7.21%

Lower costs boosted the FY24 bottom line results for Xero and management achieved the aspirational 'rule of 40' years ahead of schedule, notes the analyst at Morgans.

The broker observes Xero reported revenues in line with expectations which grew 22% year-on-year (yoy), split broadly 50:50 from new subscribers and price (average revenue per user of ARPU).

At financial year end the company had NZ$1.5bn in cash and equivalents on the balance sheet post the 250% improvement in free cashflow over the year.

Morgans adjusts FY25 and FY26 EBITDA estimates by 15% and 6%, respectively. Hold rating and the target revised to $140 from $134.80.

FORECAST
Morgans forecasts a full year FY25 dividend of 0.00 cents and EPS of 130.44 cents.
Morgans forecasts a full year FY26 dividend of 0.00 cents and EPS of 164.66 cents.

Ord Minnett

xx/xx/xxxx

5

xxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Morgan Stanley

xx/xx/xxxx

1

xxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

XRO STOCK CHART